Novel glaucoma solution enters trials

Article

INS117548, a solution designed to treat glaucoma, has entered Phase I clinical trials, according to an announcement from Inspire Pharmaceuticals Inc.

INS117548, a solution designed to treat glaucoma, has entered Phase I clinical trials, according to an announcement made by Inspire Pharmaceuticals Inc.

The Rho kinase inhibitor interferes with the actin cytoskeleton of the trabecular meshwork to lower intraocular pressure (IOP).

This placebo-controlled dose-escalating trial will appraise the compound's safety, efficacy and tolerability in early stage glaucoma or ocular hypertension.

Recent Videos
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Vikas Chopra at AAO 2024: Advancements in MIGS are transforming patient care
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
Related Content
A phone and computer with the European Medicines Agency website on them. Image credit: ©Timon – stock.adobe.com

EMA grants orphan medicinal product designation for OCU410ST (Ocugen)

Sydney M Crago
November 27th 2024
Article

OCU410ST is indicated for the treatment of ABCA4-associated retinopathies including Stargardt disease, retinitis pigmentosa and cone-rod dystrophy 3 (CORD3)

Higher molar dose and its translation into clinical practice. Led by John Kitchens, MD; Joined by Peter Kaiser, MD

Higher Molar Dose and Its Translation into Clinical Practice

John Kitchens, MD;Peter Kaiser, MD
July 22nd 2024
Podcast
On the 75th anniversary of the IOL, modern surgeons pay tribute

On the 75th anniversary of the IOL, modern surgeons pay tribute

By Artemis Matsou, MD, MRCP(UK), FEBOS-CR, FEBO, PgDip CRS; and Richard Packard, MD, FRCS, FRCOphth
November 25th 2024
Article

At the ESCRS meeting, Sir Harold Ridley’s legacy was put on display in a pop-up museum installation

A digital map of the world, overlaid on top of a photo of a person writing with a pen in a notebook. Image credit: ©Pixels Hunter – stock.adobe.com

Arctic Vision partners with Santen Pharmaceutical Co., Ltd. to commercialise ARVN001 in China

Sydney M Crago
November 22nd 2024
Article

ARVN001 is indicated for the treatment of uveitic macular oedema and certain other ophthalmic indications

A young boy inserts a contact lens while an adult supervises. ©andrey – stock.adobe.com

Incidence of microbial keratitis associated with overnight orthokeratology

Lynda Charters
November 21st 2024
Article

The incidence was comparable to that of daily wear soft contact lenses

A syringe against a multicolor background, with a drip of liquid at the end of the needle. Image credit: ©iloli – stock.adobe.com

European Commission approves aflibercept biosimilar OPUVIZ (previously SB15) from Samsung Bioepis

Sydney M Crago
November 20th 2024
Article

OPUVIZ, previously known as the biosimilar candidate SB15, has been approved for the treatment of nAMD, DME and other retinal diseases

© 2024 MJH Life Sciences

All rights reserved.